Mealey's (November 2, 2016, 10:26 AM EDT) -- SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals on Oct. 27 affirmed summary judgment in the Nexium bone injury multidistrict litigation, agreeing with the MDL court that the plaintiff’s sole general causation expert was unreliable (In Re:  Nexium Esomeprazole, Susan Orrell, et al. v. AstraZeneca Pharmaceuticals LP, et al., No. 14-56845, In Re:  Nexium Esomeprazole, Janice Allen, et al. v. AstraZeneca Pharmaceuticals LP, et al., No. 15-56848, 9th Cir.; 2016 U.S. App. LEXIS 19508).

(Opinion available.  Document #28-161103-021Z.)

Nexium is a proton pump inhibitor...